October 09, 2024
1 min watch
Save
VIDEO: No association between point mutations and blood cancer precursors
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Rosalie Griffin, PhD, discusses the results of a study into point mutations and their correlation with developing blood cancers presented at ESMO Congress 2024.
Griffin, a research associate at Mayo Clinic, highlighted the study, which probed the relationship between individual mutations on a base pair level and other known blood cancer precursors.
“They found that there really wasn't an association between those two events, which was surprising to us, but just kind of hints that there might be a different pathway as to why people are at risk based on these two different types of precursors,” Griffin said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Griffin reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.